NCT06771154: Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
- State
- Not started
- Phase
- Phase 2
- People
- 140 planned
- Started
- 1 Apr 2025
- Primary completion
- 1 Apr 2029
- Arms
- Maintenance Therapy Group with Adebrelimab Combined with Apatinib
- Results
- None posted
- 13 Jan 2025: Trial registered